Vocimagene amiretrorepvec
Vocimagene amiretrorepvec Uses, Dosage, Side Effects, Food Interaction and all others data.
Vocimagene amiretrorepvec is under investigation in clinical trial NCT02576665 (A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)).
| Trade Name | Vocimagene amiretrorepvec |
| Generic | Vocimagene amiretrorepvec |
| Vocimagene amiretrorepvec Other Names | Vocimagene amiretrorepvec |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Vocimagene amiretrorepvec
